Compare Amgen, Inc. (AMGN) vs Hormel Foods Corp (HRL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs Hormel Foods Corp — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while Hormel Foods Corp trades at $24.52 (market cap $13.61B). The key difference: Amgen, Inc. is far larger — about 14.4× Hormel Foods Corp's market cap, and Hormel Foods Corp pays the higher dividend (4.73%). Which is the better fit depends on your goals.
| AMGN | HRL | |
|---|---|---|
Market Cap | $196.12B | $13.61B |
Sector | Health | Consumer Staples |
52-Week High | $388.16 | $30.51 |
52-Week Low | $271.18 | $19.74 |
Enterprise Value | $241.41B | $15.61B |
Dividend Yield | 2.77% | 4.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Hormel Foods (HRL) trades at $24.735, up 1.66% today, with a bearish technical signal but consistent earnings beats in recent quarters. The company maintains a 60-year dividend growth streak, paying $0.29 quarterly, while navigating margin pressures with a 3.82% net income margin. Recent news highlights strategic moves like the Ceratti Brazil sale to sharpen growth focus, though revenue trends remain flat near $12.1B.
Outlook is mixed: valuation appears reasonable (P/E 29.09, P/S 1.11) with analyst consensus at $26.00, but risks include volatile cash flows and competitive pressures. The stock offers income stability via dividends, yet investors face headwinds from inflation and sluggish profit growth, requiring patience for a turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →
